Parus Finance (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-407
Closed -$317K 33
2025
Q2
$317K Hold
407
0.09% 31
2025
Q1
$336K Sell
407
-26
-6% -$21.6K 0.11% 31
2024
Q4
$334K Hold
433
0.1% 31
2024
Q3
$384K Sell
433
-12,170
-97% -$10.9M 0.12% 31
2024
Q2
$11.4M Buy
12,603
+2,994
+31% +$2.39M 3.3% 11
2024
Q1
$7.48M Buy
+9,609
New +$6.84M 2.82% 13

Other funds holding LLY

Parus Finance (UK)'s LLY Position: Q3 2025 in Review

Parus Finance (UK) sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 407 shares — an estimated $317K sold.

Parus Finance (UK) first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $11.4M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Parus Finance (UK) reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Parus Finance (UK) sold 407 Eli Lilly shares in Q3 2025, an estimated $317K.
  • Parus Finance (UK) first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • Parus Finance (UK)'s Eli Lilly position peaked at $11.4M in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Parus Finance (UK)'s 13F filing for Q3 2025, filed 12 Nov 2025.